Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

Summary

In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TrueLab, discussing his journey from finance to the pharmaceutical industry, the impact of personal experiences on innovation, and the importance of technology in clinical trials. They explore how to hire the best employees in this climate, the significance of company culture, and the influence of family on business perspectives.

Chapters

00:00 Introduction to BioTalk Unzipped

03:15 The Impact of Personal Experience on Innovation

08:47 TruLab's Technology and Its Role in Clinical Trials

14:33 The Importance of Sample Management and the Genesis of TruLab

20:33 NEW NEWS! – The Future of Cancer Treatments

23:34 Hiring Patterns and the value of Company Culture

Takeaways

  • Scott Ogle's personal experience with his father's illness inspired the creation of TruLab.

  • TruLab focuses on eliminating inefficiencies in clinical trial sample management.

  • The importance of having fun in one's career for productivity and happiness.

  • Hiring for energy and cultural fit is crucial for company success.

  • More young people out of college actually prefer working in the office, so it’s a hiring advantage.


Sound Bites

  • “Entrepreneurs get excited about their solution but can forget about what problem they’re solving.”

  • "We need to iterate on technology in clinical trials."

  • “20-25% of biological samples get tossed out.”

  • "You can't coach energy in a candidate."

  • “Company values. Senior leadership must beat it like a drum.”

  • “Interviewing candidates on company values is your North Star.”

  • “Go by what people do, not by what they say.”

  • “Hallway meetings, that’s where stuff gets done.”


New News Story:


How to reach us:

Scott Ogle

https://www.linkedin.com/in/scott-ogle/

TruLab - https://trulab.com/

Leukemia & Lymphoma Society - https://www.lls.org/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Keywords: Scott Ogle, TruLab, clinical trial technology, biotech innovation, sample management in clinical trials, hiring for company culture, company values in leadership, finance to pharma journey, revolutionizing clinical trials, impact of personal experience on innovation, biotechnology leadership, clinical trial inefficiencies, cancer treatment news, digital transformation in pharma, family influence in business, company culture in biotech, pharmaceutical funding challenges, ISB 2001 trispecific T cell engager.

Tags: #ScottOgle, #TruLab, #ClinicalTrials, #Biotech, #PharmaInnovation, #Sample Management, #Company Culture, #Hiring Tips, #BiotechLeadership, #PharmaTechnology, #CancerTreatment, #PersonalInnovation, #BiotechFunding, #LeadershipInPharma, #BusinessLeadership, #PharmaceuticalIndustry.

Episoder(42)

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

Innovation: The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Innovation: The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025 In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Ge...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai

Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe interview Asst. Professor Pin-Kuang Lai from Stevens Institute of Technology about his keynote speech at AAPS NBC 2025 an...

12 Sep 202517min

The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics

The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics

In this powerful episode (#35) of BioTalk Unzipped, recorded live at the AAPS NBC conference in Boston, Gregory Austin engages in a deep conversation with a leading Neuroscientist, Dr. Robert Thorne, ...

3 Jul 202522min

Inside AAPS NBC with AAPS President Dr. Russ Weiner

Inside AAPS NBC with AAPS President Dr. Russ Weiner

In this special episode (#34) of BioTalk Unzipped, recorded live at the AAPS NBC conference in Boston, Gregory Austin and Dr. Chad Briscoe sit down with AAPS President Dr. Russ Weiner for an unfiltere...

8 Jun 202528min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
utbytte
rss-politisk-preik
finansredaksjonen
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
livet-pa-veien-med-jan-erik-larssen
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
rss-pa-konto
rss-sunn-okonomi
lederpodden
rss-investering-gjort-enkelt